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PURPOSE: Chemical pleurodesis is a therapeutic tool for the treatment of recurrent pleural effusions, mainly those of neoplastic
etiology. In the past, tetracycline was the sclerosant agent of choice in clinical practice, but presently, there is no consensus about
an ideal agent. The aim of this study was to evaluate the effectiveness of macrolides (azithromycin and clarithromycin) or quinolones
(levofloxacin and gatifloxacin) in inducing experimental pleurodesis in rabbits.
METHOD: Forty New Zealand rabbits randomized into groups of 10 received (at a total volume of 2 mL for each animal) 1 of the
4 drugs by intrapleural injection. After 28 days, the animals were euthanized and the pleural cavity was evaluated macroscopically
and microscopically.
RESULTS: The intensity of the macroscopic adhesions was mild in all groups. On microscopic analysis, minimal pleural fibrosis
and inflammation were observed in all animals.
CONCLUSION: The macrolides (azithromycin or clarithromycin) and the quinolones (levofloxacin or gatifloxacin) when injected
into the normal pleural space of rabbits are not effective in promoting pleurodesis. Additional research is required to identify
sclerosing agents capable of inducing pleurodesis.
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INTRODUCTION
Chemical pleurodesis is a method used to treat recur-
ring pleural effusions, especially those with malignant
etiology in which symphysis between the pleural layers is
needed.1 Intrapleural instillation of a sclerosing agent that
acts on the mesothelial layer leads to an inflammation that
progresses to a fibrotic process and coalesces the parietal
and visceral layers, obliterating the pleural space and pro-
ducing pleurodesis.1
The choice of a sclerosing agent is still controversial.
An ideal sclerosant would be low cost, easily available,
easily manipulated and sterilized; it would produce low
morbidity (eg, pain should be easily controlled), and no
mortality.2 To date, no sclerosant agent with all these char-
acteristics has been identified.
The most frequently used sclerosants are antibiotics
(doxycycline), antineoplastic agents (bleomycin),
immunostimulants (C. parvum), and irritants (talc).2 The
effectiveness of antibiotics varies between 60% and 80%,
of antineoplastic agents between 60% and 70%, and for ir-
ritants, it is generally greater than 90%.2,3 Although talc
might be considered an ideal agent, several cases of acute
respiratory distress syndrome have been reported in asso-
ciation with talc pleurodesis.2,4,5
Among antibiotic sclerosants, tetracycline was the first
choice for several decades. It was abandoned as a result of
a commercial decision that discontinued its production.2
Derivatives of tetracycline, doxycycline and minocycline,
were its natural replacements for inducing pleurodesis.2,6-8
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Macrolides have been used to induce pleurodesis. Eryth-
romycin was used in an experimental model as a sclerosing
agent, with inflammation and fibroblast proliferation be-
ing evident after 8 days.9 In a clinical trial evaluating 15
patients with malignant pleural effusion, erythromycin was
effective inducing pleurodesis in 84% of cases.10
Quinolones are widely used broad-spectrum antibiotics.
Nevertheless, as far as we know, there have been no clini-
cal or experimental studies evaluating pleural sclerosis pro-
duction with this drug.
This study aimed to evaluate, using an experimental
model in rabbits, the effectiveness of intrapleural instilla-
tion of macrolides (azithromycin or clarithromycin) or
quinolones (levofloxacin or gatifloxacin) in inducing
pleurodesis.
METHODS
This study was carried out at the Pleura Laboratory and
the Research Division of the Heart Institute, Hospital das
Clínicas, São Paulo University Medical School [HC-
FMUSP], having been previously approved by the Institu-
tional Ethics Committee.
Forty New Zealand rabbits weighing 2.0 to 3.0 kg,
randomized into 4 groups (with 10 animals each), received
(in a total volume of 2 mL) by intrapleural injection, 15
mg/kg of azithromycin or clarithromycin or 10 mg/kg of
levofloxacin or gatifloxacin.
The surgical procedure followed a previously described
methodology.8,11,12 After anesthesia by intramuscular injection
(35 mg/kg of ketamine HCl and 5 mg/kg of xylazine hydro-
chloride), the animals were prepared for aseptic surgery. Af-
ter an incision (0.5 cm) in the right hemithorax, the parietal
pleura was exposed and the sclerosing agent was injected into
the pleural space through a drain (6F); the surgical wound was
closed by sutures. The drain, aspirated daily, was removed after
48 hours if the daily fluid outflow was less than 1 mL/day.
The left hemithorax served as a control and did not receive
intrapleural instillation of any substance or drain.
According to the protocol, animals exhibiting apparent
distress were immediately euthanized.
After 28 days, the surviving animals were euthanized
by an IV injection of 40 mg/kg of pentobarbital into the
marginal ear vein. The thorax was removed en bloc, and
the lungs were expanded with 60 mL of 10% formalin and
immerged in this solution for at least 48 h. After this pe-
riod, each pleural cavity was exposed using the method pre-
viously described by our group.13-16 Then, with the thorax
opened, we evaluated the presence of macroscopic pleural
adhesions and collected fragments from the pleura and pul-
monary parenchyma for later microscopic analysis.
Table 1 summarizes scoring scheme for adhesion, atel-
ectasis, and fluid collection. Such scores were established
in order to macroscopically quantify the degree of pleural
adhesion (0-4), atelectasis (0-2), and fluid collection (0-4).
Pleurodesis was considered effective when the degree of
pleural adhesions was equal to or greater than a score of
311-16 and no presence of atelectasis or fluid collection. Ta-
ble 1 also shows the scores used to quantify collected frag-
ments of pleura and parenchyma; these were processed and
stained with hematoxylin and eosin. Similarly to the mac-
roscopic assessment, we based our microscopic analysis on
previously validated scores,13-16 quantifying the degree of
inflammation and fibrosis (0 to 4).
The descriptive statistics developed were mean and
standard deviation. Group means were tested for signifi-
cant differences using the t test to compare the 2 groups
of antibiotics (macrolides vs quinolones) and ANOVA fol-
lowed by multiple comparison tests (Tukey or Dunn) to
compare the groups among themselves. Statistical signifi-
cance was considered when the difference was less than
or equal to 0.05.
RESULTS
Only 1 death was observed, and it occurred on the sec-
ond postoperative day. Necropsy revealed no significant al-
terations in the pleural space that could have contributed
to the lethal outcome (this case was excluded from the sta-
tistical analysis). The side effects of the drugs injected were
acute episodes of diarrhea 3 hours after the intrapleural in-
jection in more than 75% of the animals that received
Table 1 - Scoring scheme for the macroscopic and microscopic evaluations of the pleura
degree of 0 1 2 3 4
adhesions normal pleura 1 - 3 small > 3 adhesions generalized pleural space
(easy separation*) (difficult separation*) obliteration
atelectasis none partial total — —
fluid colletion† absent < 25% ≥25 – <50% ≥50 – <75% ≥75% of cavity
inflammation and normal pleura and minimal discreet moderate severe
fibrosis parenchima
*: lung thorax separation; †: % of cavity
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azithromycin or clarithromycin. After 24 hours, the animals
returned to normalcy, and no drug intervention was neces-
sary. These episodes of diarrhea were not observed with
the intrapleural use of quinolones.
No animal presented pleural fluid during the 48 hours
after injection of the sclerosing agent (the period in which
the drain remained in the animals), and this made sampling
for further biochemical or cytological fluid analysis impos-
sible.
Macroscopic Analysis
The intensity of the adhesions (Table 2) was discreet
in the groups that received macrolides (1.25 ± 0.75) and
in those receiving quinolones (0.64 ± 0.63), and no sig-
nificant difference (P = 0.057) was observed between them.
The scores attributed to the adhesions in the animals that
received azithromycin (1.25 ± 0.50), clarithromycin (1.25
± 1.04), levofloxacin (1.00 ± 0.53), or gatifloxacin (0.16
± 0.41) were significantly different (P = 0.033), although
significant differences were not found from the multiple
comparisons test.
In all animals, the left hemithorax, used as a control
because it had not been injected with the agent, received a
score of 0.
Microscopic Analysis
The microscopic changes observed in the visceral pleura
resulting from the intrapleural injection of the agents in-
vestigated were minimal on the right and absent (score =
0) on the left. These results (Table 3) were both observed
in the group dosed with macrolides (fibrosis: 0.94 ± 0.73,
inflammation: 0.37 ± 0.52) and in the group dosed with
quinolones (fibrosis: 0.43 + 0.51, inflammation: 0.36 ±
0.50), with no significant differences (fibrosis: P = 0.108,
inflammation: P = 0.973).
The pleural fibrosis scores resulting from injections of
azithromycin (0.37 ± 0.48), clarithromycin (1.50 ± 0.41),
levofloxacin (0.62 ± 0.52), or gatifloxacin (0.17 ± 0.41)
were significantly different one from the other (P = 0.002).
Tukey’s test showed that this difference was a result of the
comparison between clarithromycin and the other drugs.
Regarding pleural inflammation, there was no signifi-
cant difference among the groups (P = 0.553). The scores
attributed were 0.25 ± 0.50; 0.50 ± 0.58; 0.50 ± 0.54, and
0.17 ± 0.41 for azithromycin, clarithromycin, levofloxacin,
and gatifloxacin, respectively.
The pulmonary parenchyma was not affected by the in-
trapleural injection of these agents (score = 0).
DISCUSSION
This study demonstrates that the intrapleural injection
of azithromycin, clarithromycin, levofloxacin, or gati-
floxacin is not effective in inducing pleurodesis in an ex-
perimental rabbit model. The degree of pleural adhesion
after the intrapleural injection of these drugs was notably
inferior to that observed in a prior study after the pleural
instillation of talc (2.2 ± 0.7) or silver nitrate (3.2 ± 1.1).12
The choice of an ideal pleural sclerosing agent is still
object of research and is based on efficacy, morbidity-mor-
tality, ease in manipulation, availability, and cost. It is note
worthy that although the century have elapsed since
pleurodesis was first performed (1901)2,7, the ideal agent
only have far been identified. The nonexistence of a sub-
stance that satisfies all the basic prerequisites and clinical
needs explains the ongoing research, including the revival
of studies on agents that had been used in the past.17,18
The interest in antibiotics as pleural sclerosing agents
dates back to the early phases of studies on pleurodesis.
The first antibiotic used in clinical practice was tetracy-
cline, which was used until the 1980s when production of
the injectable form was discontinued. Tetracycline was im-
mediately replaced, although without the same impact, by
its natural derivatives, doxycycline, and minocycline.2,3
Tetracycline, employed as a pleural sclerosing agent in hu-
mans for more than 20 years, was effective in inducing
pleurodesis in approximately 70% of cases, surpassing the
currently achieved results obtained with doxycycline and
minocycline that experimentally produce pleurodesis in
about 80% of injected animals, but can result in
hemothorax and death.8
In addition to tetracycline and its derivatives,
macrolides, represented by erythromycin, were evaluated
for sclerosing effects both in experimental models and in
humans. In animals, after a period of 8 days, the intrap-
leural instillation of erythromycin produces marked inflam-
mation, allowing recognition of its irritant action on pleu-
ral layers and suggesting a potential sclerosing effect.9 This
effect was later confirmed in humans (26 patients) in whom
Table 2 - Scores of pleural adhesions observed macros-
copically in the injected hemithorax
ANTIBIOTICS PLEURAL ADHESIONS p* p§
Macrolides 1.25 ± 0.75 0.057
Quinolones 0.64 ± 0.63
Azithromycin 1.25 ± 0.50 0.033
Clarithromycin 1.25 ± 1.04
Levofloxacin 1.00 ± 0.53
Gatifloxacin 0.17 ± 0.41
*macrolides x quinolones (t test); §azithromycin x clarithromycin x
levofloxacin x gatifloxacin (ANOVA)
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effectiveness was observed in 85% of patients with
neoplastic pleural effusion, with a complete response in 15
(58%). In these 85% (22) of patients, the formation of nu-
merous pleural adhesions and control of the pleural effu-
sion was noted.10
It is important to note that antibiotics, provided that they
are inexpensive, effective, and cause few side effects, could
be considered ideal agents due to their wide availability.
The established sclerosing effectiveness of tetracycline and
erythromycin (macrolides), justifies further investigation
with other antibiotics.
The mechanisms responsible for producing pleurodesis
are not completely clear. Apparently, the instillation of a
sclerosing agent causes damage to the mesothelial layer
with the subsequent formation of an inflammatory pro-
cess, characterized by the production of exudative fluid.1,2
In spite of prior reports9,10 describing the effectiveness
of erythromycin, other macrolides such as azithromycin and
clarithromycin were not capable of producing a pleural in-
flammatory process intense enough to induce the forma-
tion of pleurodesis. No exudation, evidenced by the pres-
ence of pleural effusion, was seen during the first 48 hours
of observation. This absence of pleural fluid correlates with
the data noted both in the macroscopic and microscopic
evaluations.
The nonexistence of fluid suggests a mild effect of
these drugs on the pleura. The pleural fluid, characteris-
tically an exudate, expresses acute inflammatory altera-
tions that are the beginning of a succession of events lead-
ing to the development of pleural adhesions and the re-
sulting pleurodesis formation. Factors capable of interfer-
ing in this progress include the intensity of the injury, the
capacity of the mesothelial cells and fibroblasts to secrete
collagen, the relative equilibrium between the metalo-
proteinases and their inhibitors, and the balance between
the activators and inhibitors of plasminogen, in addition
to the relationship between the inflammation and the
pro-inflammatory cytokines with fibrinolysis mecha-
nisms.19,20
Earlier studies9,10 showing the sclerosing action of eryth-
romycin led to the hypothesis that other macrolides
(azithromycin or clarithromycin) might also be capable of
promoting mesothelial layer damage sufficient to produce
pleural effusion and subsequent pleural adhesions. This was
not observed in this study, which might be explained by
pharmacokinetic characteristics. In theory, these antibiot-
ics would be rapidly absorbed and might not remain in the
pleural cavity long enough to cause mesothelial damage
and initiate the necessary inflammatory process. The ob-
servation of diarrhea 3 hours after intrapleural dosing of
the macrolides suggests precocious systemic manifestations
resulting from the rapid absorption and distribution of these
antibiotics.
With the objective of finding sclerosing agents with an
effect similar to that of tetracycline, and considering the
current ample use and wide distribution of quinolones, we
chose to evaluate the possible effects of inducing
pleurodesis with levofloxacin and gatifloxacin, even though
there are no past reports (as far as we know) on the use of
these antibiotics.
The pleural adhesions observed after instillation of these
agents were not encouraging: there was no acute evidence
of pleural fluid formation, and the degree of inflammation
noted at microscopic assessment after 28 days was irre-
levant, because the degree of pleural adhesion resulting
from the experimental treatment was not considered ad-
equate. Therefore, the quinolones analyzed (levofloxacin
and gatifloxacin) produced minimal damage to the mes-
othelium. Thus, the succession of events that might cul-
minate in macroscopically visible pleural adhesions , and
microscopically recognizable fibrosis was not established.
The statistical difference observed among the 4 groups
analyzed in the macroscopic evaluation of adhesions and
the microscopic evaluation of pleural fibrosis was not sub-
stantial and has no concrete significance since those scores
are irrelevant as noted above.
Although the sclerosing effect of erythromycin had pre-
viously been demonstrated in clinical and experimental
Table 3 - Scores for pleural fibrosis and inflammation observed microscopically in the injected hemithorax
 ANTIBIOTICS FIBROSIS INFLAMMATION
X ± SD p* pP§ X + SD p* p§
Macrolides 0.94 ± 0.73 0.108 0.37 ± 0.52 0.973
Quinolones 0.43 ± 0.51 0.36 ± 0.50
Azithromycin 0.37 ± 0.48 0.002 0.25 ± 0.50 0.553
Clarithromycin 1.50 ± 0.41 0.50 ± 0.58
Levofloxacin 0.62 ± 0.52 0.50 ± 0.54
Gatifloxacin 0.17 ± 0.41 0.17 ± 0.41
*macrolides x quinolones; §azithromycin x clarithromycin x levofloxacin x gatifloxacin
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studies,9,10 no significant pleural adhesion was noted in the
present experiments, after the intrapleural injections of
azithromycin or clarithromycin, also belonging to the mac-
rolide class. Similarly, the studied quinolones (levofloxacin
and gatifloxacin) showed no pleural sclerosing effect in our
experimental model and therefore should not be considered
for use in humans.
These negative results are deliberately collected and
offered as a finished study because we firmly believe that
they add important data to the field, indicating that addi-
tional drugs must be tested with the purpose of identify-
ing the ideal pleural sclerosant.
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RESUMO
Teixeira LR, Vargas FS, Acencio MMP, Bumlai RUM,
Antonangelo L, Marchi E. Pleurodese experimental
induzida por antibióticos (macrolídeos e quinolonas). Clin-
ics. 2006;61(6):559-64.
OBJETIVO: A pleurodese química representa uma
ferramenta terapêutica utilizada no tratamento dos processos
pleurais recidivantes, principalmente nos derrames
neoplásicos. A escolha do melhor esclerosante pleural é ainda
motivo de controvérsia, não havendo consenso com relação
ao agente considerado ideal. O objetivo deste estudo é avaliar
a efetividade dos macrolídeos (azitromicina e claritromicina)
e das quinolonas (levofloxacina e gatifloxacina) na indução
de pleurodese experimental em coelhos.
MÉTODOS: Quarenta animais randomizados em grupos
de 10, receberam, em volume total de 2 mL, estas drogas
através de injeção intrapleural.
RESULTADOS: Após 28 dias, os animais foram
sacrificados sendo avaliada a cavidade pleural. A
intensidade das aderências macroscópicas assim como da
fibrose e da inflamação observadas à microscopia foi
discreta tanto no grupo que recebeu macrolídeos quanto
naquele que recebeu quinolonas.
CONCLUSÃO: Azitromicina, Claritromicina,
Levofloxacina e Gatifloxacina quando injetados na
cavidade pleural de coelhos, não são eficazes na indução
de pleurodese. Novas pesquisas devem ser realizadas com
o intuito de identificar agentes esclerosantes capazes de
produzir sínfise pleural.
UNITERMOS: Pleurodese. Macrolídeos. Quinolonas.
Azitromicina. Claritromicina. Levofloxacina. Gatifloxacina.
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